With Support from BARDA and NIH, First Phase 3 Clincial Trail of a COVID-19 Vaccine Begins in the United States

[advanced_iframe src=”https://view.connect.hhs.gov/?qs=a5712239be29718abcf51c1b450ae3c77c6844c4726400e97345754e1c566a810192cd45e60dc8d567a8a6fb19beedb7a5b5b6ffe80eef8a6d76d13f20b973384ccc19cbfed619c0″ width=”100%” height=”2600″]